Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Archives of Pathology & Laboratory Medicine



HOLOGIC – Empower Your Genius With Ours
The Genius Digital Diagnostics System is the first and only FDA cleared digital cytology system –
combining a new artificial intelligence (AI) with advanced volumetric imaging technology
to help cytologists and pathologists identify pre-cancerous lesions and cervical cancer cells.

 

 

Archives of Pathology & Laboratory Medicine AI-Generated Podcasts

Archives of Pathology & Laboratory Medicine now offers the option to listen to a discussion of select articles with voices reminiscent of a Siri or Garmin speaker. In fact, the voices that you will hear are completely AI generated. Since this AI-generated podcast uses technology that is still in its early stages of development, there may be some errors in pronunciation and the tone may sound too upbeat for the material covered.

 

[one_third]

[/one_third]

[two_third_last]

PUBLISHED DECEMBER 5, 2024

Introduction to Generative Artificial Intelligence: Contextualizing the Future

Context:
Generative artificial intelligence (GAI) is a promising new technology with the potential to transform communication and workflows in health care and pathology. Although new technologies offer advantages, they also come with risks that users, particularly early adopters, must recognize. Given the fast pace of GAI developments, pathologists may find it challenging to stay current with the terminology, technical underpinnings, and latest advancements. Building this knowledge base will enable pathologists to grasp the potential risks and impacts that GAI may have on the future practice of pathology.

Objective:
To present key elements of GAI development, evaluation, and implementation in a way that is accessible to pathologists and relevant to laboratory applications.

Listen to a discussion of this article through our AI-generated podcast.

[/two_third_last]

[one_third]

[/one_third]

[two_third_last]

PUBLISHED SEPTEMBER 30, 2024

Harnessing the Power of Generative Artificial Intelligence in Pathology Education

Context:
Generative artificial intelligence (AI) technologies are rapidly transforming numerous fields, including pathology, and hold significant potential to revolutionize educational approaches.

Objective:
To explore the application of generative AI, particularly large language models and multimodal tools, for enhancing pathology education. We describe their potential to create personalized learning experiences, streamline content development, expand access to educational resources, and support both learners and educators throughout the training and practice continuum.

Listen to a discussion of this article through our AI-generated podcast.

[/two_third_last]

[one_third]

[/one_third]

[two_third_last]

PUBLISHED SEPTEMBER 20, 2024

Ethical and Regulatory Perspectives on Generative Artificial Intelligence in Pathology

Context:
Technology companies and research groups are increasingly exploring applications of generative artificial intelligence (GenAI) in pathology and laboratory medicine. Although GenAI holds considerable promise, it also introduces novel risks for patients, communities, professionals, and the scientific process.

Objective:
To summarize the current frameworks for the ethical development and management of GenAI within health care settings.

Listen to a discussion of this article through our AI-generated podcast.

[/two_third_last]

[one_third]

[/one_third]

[two_third_last]

PUBLISHED OCTOBER 10, 2024

Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice

Context:
Generative artificial intelligence (GAI) technologies are likely to dramatically impact health care workflows in clinical pathology (CP). Applications in CP include education, data mining, decision support, result summaries, and patient trend assessments.

Objective:
To review use cases of GAI in CP, with a particular focus on large language models. Specific examples are provided for the applications of GAI in the subspecialties of clinical chemistry, microbiology, hematopathology, and molecular diagnostics. Additionally, the review addresses potential pitfalls of GAI paradigms.

Listen to a discussion of this article through our AI-generated podcast.

[/two_third_last]